Bicycle Therapeutics plc
BCYC
$4.10
$0.092.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.12% | 61.13% | -16.33% | -98.31% | -128.72% |
| Total Depreciation and Amortization | -30.91% | -21.60% | -19.15% | 3.41% | -1.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.30% | 159.09% | 10.77% | -1.70% | -3.83% |
| Change in Net Operating Assets | 63.65% | -136.25% | -2,548.86% | 70.51% | 34.89% |
| Cash from Operations | 23.67% | -105.90% | -78.68% | -63.10% | -21.87% |
| Capital Expenditure | -18.05% | -55.98% | -54.94% | -18.57% | -4,933.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -18.05% | -55.98% | -54.94% | -18.57% | -4,933.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -53.49% | -14.29% | 99.90% | -- | -- |
| Issuance of Common Stock | 500.00% | -86.53% | -- | -100.00% | -99.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -31.71% | -107.39% | 99.91% | -100.01% | -102.19% |
| Foreign Exchange rate Adjustments | -515.38% | 87.54% | -173.69% | 1,041.15% | 212.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.70% | -77.72% | -3.72% | -114.18% | -24.66% |